InvestorsHub Logo

Joseph_K

08/28/23 6:21 PM

#428757 RE: abew4me #428756

Wouldn't Anavex want to run Phase 2 trials anyway for dissimilar indications in order to establish proper dosage for the Phase 3 trials? For example, the doses used in the adult Rett trial were much lower than in the Alzheimer's trials.